drugset

Drugs / benfluorex

Follow last change Oct 2008 re-read 3 minutes ago

benfluorex

also known as BENFLUOREX HYDROCHLORIDE · Mediaxal · NSC-757396

Small molecule targets SOAT1 via inhibition

Developed for: type 2 diabetes mellitus
Investigated by: Air Force Military Medical University, China · Beijing Army General Hospital · Beijing Haijinge medicine Science-tech CO.,LTD(CRO) · Bethune International Peace Hospital · Center for Drug Clincal Reserch Shanghai University of TCM · Second Hospital of Jilin University
+2 more
· Shandong Xinhua Pharmaceutical Company Limited in China · The People's Hospital of Hebei Province

Trials 1

today NCT00544518 · Ph 2

20082009201020112012201320142015201620172018201920202021202220232024202520262027

Phase	Registry id	Dates	Indication	Sponsor	Status	Outcome
Phase 2	NCT00544518	Oct 2007 → Sep 2008	type 2 diabetes mellitus	Air Force Military Medical University, China	Unknown	No outcome recorded

Evidence & citations 7 cited values

Every value below carries the sentence it was read from. 2 sources stand behind the page.

Field	Value	Cited text
Known as	benfluorex	ClinicalTrials.gov intervention name — accepted as the source's own label NCT00544518 ↗
Known as	BENFLUOREX HYDROCHLORIDE	ChEMBL registry synonym — accepted as the source's own label CHEMBL400599 ↗
Known as	Mediaxal	ChEMBL registry synonym — accepted as the source's own label CHEMBL400599 ↗
Known as	NSC-757396	ChEMBL registry synonym — accepted as the source's own label CHEMBL400599 ↗
Action	Inhibit	“Acyl coenzyme A:cholesterol acyltransferase 1 inhibitor” CHEMBL400599 ↗
Modality	Small molecule	— CHEMBL400599 ↗
Target	SOAT1	“Acyl coenzyme A:cholesterol acyltransferase 1 inhibitor” CHEMBL400599 ↗